ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.
Kane Biotech Inc

Kane Biotech Inc (KNE)

0.13
0.00
( 0.00% )
업데이트: 01:29:12

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
0.13
매수가
0.125
매도가
0.13
거래량
15,000
0.125 일간 변동폭 0.13
0.05 52주 범위 0.17
market_cap
전일 종가
0.13
개장가
0.125
최근 거래 시간
5000
@
0.13
마지막 거래 시간
01:29:12
재정 규모
-
VWAP
-
평균 볼륨(3m)
124,267
발행 주식
131,844,000
배당수익률
-
주가수익률
-3.25
주당순이익(EPS)
-0.04
매출
2.82M
순이익
-5.27M

Kane Biotech Inc 정보

섹터
Coml Physical, Biologcl Resh
산업
Coml Physical, Biologcl Resh
웹사이트
본부
Winnipeg, Manitoba, Can
설립됨
-
Kane Biotech Inc is listed in the Coml Physical, Biologcl Resh sector of the TSX 벤처 거래소 with ticker KNE. The last closing price for Kane Biotech was $0.13. Over the last year, Kane Biotech shares have traded in a share price range of $ 0.05 to $ 0.17.

Kane Biotech currently has 131,844,000 shares in issue. The market capitalisation of Kane Biotech is $17.14 million. Kane Biotech has a price to earnings ratio (PE ratio) of -3.25.

KNE 최신 뉴스

Kane Biotech to Participate in a Multinational Corporate Collaboration Project

WINNIPEG, Manitoba, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that it is receiving advisory services and...

Kane Biotech Announces Attendance at Upcoming Wound Care Conferences

WINNIPEG, Manitoba, Sept. 26, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that the Company will be showcasing its...

Kane Biotech Announces Exercise of Warrants

WINNIPEG, Manitoba, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces the exercise of an aggregate of 5 million warrants at an...

Kane Biotech Announces Second Quarter 2024 Financial Results

WINNIPEG, Manitoba, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) today announces its second quarter 2024 financial...

Kane Biotech Announces new DispersinB® Publication in Pathogens and Conference Presentations

WINNIPEG, Manitoba, Aug. 29, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces the publication of a new review article on DispersinB® in...

Kane Biotech Announces Distribution Agreement with Qatar Datamation Systems for revyve™ Antimicrobial Wound Gel

WINNIPEG, Manitoba, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it has signed a three year distribution...

Kane Biotech to Release Second Quarter 2024 Financial Results on August 29, 2024 – Conference Call to Follow

WINNIPEG, Manitoba, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”) will announce its second quarter 2024 financial results after market close on...

Kane Biotech Announces Distribution Agreement with Razan Medical Trading for revyve™ Antimicrobial Wound Gel

WINNIPEG, Manitoba, Aug. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it has signed a three year distribution...

Kane Biotech Receives Funding Support to Expand the revyve™ Antimicrobial Wound Gel Family

WINNIPEG, Manitoba, Aug. 13, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that it is receiving advisory services and...

Kane Biotech Receives FDA Approval to Increase Dosage Allowance of its revyve™ Antimicrobial Wound Gel

WINNIPEG, Manitoba, July 23, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”) announces that the US Food and Drug Administration...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.005-3.70370370370.1350.140.12914240.13505469CS
4000.130.1450.121366800.13025647CS
12-0.015-10.34482758620.1450.160.121242670.14377157CS
26-0.03-18.750.160.170.111458950.13809917CS
520.07116.6666666670.060.170.051006040.1253662CS
156-0.04-23.52941176470.170.1850.05659870.11787492CS
260-0.005-3.70370370370.1350.260.05664120.13613719CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
KUAI.PKua Investments Inc
$ 0.03
(200.00%)
5k
ETUE2gold Inc
$ 0.01
(100.00%)
52k
AUR.HAurora Royalties Inc
$ 0.02
(100.00%)
7k
SOP.HSoperior Fertilizer Corp
$ 0.01
(100.00%)
1,000
ADEAdex Mining Inc
$ 0.01
(100.00%)
100k
SCLTSearchlight Resources Inc
$ 0.005
(-50.00%)
1,000
NICKNickelex Resource Corporation
$ 0.005
(-50.00%)
1M
EGTEguana Technologies Inc
$ 0.005
(-50.00%)
4.68M
SHLL.PShellron Capital Ltd
$ 0.055
(-47.62%)
3k
FGCC.PFirst And Goal Capital Corp
$ 0.10
(-33.33%)
1,000
EGTEguana Technologies Inc
$ 0.005
(-50.00%)
4.68M
THRMTherma Bright Inc
$ 0.045
(-10.00%)
2.75M
WCUWorld Copper Ltd
$ 0.09
(12.50%)
2.7M
MERGMetal Energy Corp
$ 0.03
(0.00%)
2.38M
MASMas Gold Corp
$ 0.01
(-33.33%)
2.34M

KNE Discussion

게시물 보기
teq0904 teq0904 10 월 전
They have been making about 2,500 samples per month in their lab for distribution to doctors for more than a month. By the time the contract plant starts up at the end of March there will be over 10k samples out so lots of doctors will be familiar with the product. You can bet they went to the burn centers and other of their top identified markets first.
👍️0
teq0904 teq0904 12 월 전
Latest video on kne
https://www.facebook.com/KaneBiotechInc/videos/292568703569665
👍️0
teq0904 teq0904 1 년 전
cc on Tuesday
👍️0
teq0904 teq0904 1 년 전
Doesn't matter what you think the dog market is, because it will be sold. Strategic review nr.
👍️0
teq0904 teq0904 1 년 전
First closing of the financing is probably next week. Officers and directors are in on it.
👍️0
teq0904 teq0904 1 년 전
On the previous cc, Edwards said it is possible that the FDA will approve the manufacturing plant in time for the sales to start in Q4.
👍️0
teq0904 teq0904 1 년 전
The next quarterly cc will be late in August.
👍️0
teq0904 teq0904 1 년 전
The next step is for the outsourced manufacturing of coactiv+ to be completed. It may already be done, but it was supposed to take 3 months after receiving FDA approval.
👍️0
teq0904 teq0904 1 년 전
They have FDA approval for coactiv+.
👍️0
J_Dean J_Dean 3 년 전
This is the year. Let’s go! :)
👍️0
Golden Cross Golden Cross 5 년 전
Kane Biotech Announces Third Quarter 2019
Financial Results

https://backend.otcmarkets.com/otcapi/company/dns/news/document/40388/content
👍️0
Golden Cross Golden Cross 5 년 전
KNBIF Website:

https://www.kanebiotech.com/
👍️0
Golden Cross Golden Cross 5 년 전
Kane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (56 patents and patents pending, trade secrets and trademarks) and products developed by the Company’s own biofilm research expertise and acquired from leading research institutions. StrixNBTM, DispersinB®, Aledex®, bluestemTM, AloSeraTM, coactiv+TM and Kane® are trademarks of Kane Biotech Inc. The Company is listed on the TSX Venture Exchange under the symbol "KNE".
👍️0
Golden Cross Golden Cross 5 년 전
Monster # of filings today $KNBIF

https://www.otcmarkets.com/stock/KNBIF/disclosure
👍️0
sfld sfld 5 년 전
This might pump this week. Mentioned in a National Inflation Association newsletter today. GLTA
👍️0
pegcitygreen pegcitygreen 5 년 전
I live in Winnipeg and have personally worked with this company. Great people, great products, but the company itself always seems to struggle. Kane products are for wealthy/well off people who love their pets and more than likely do not have any kids. A very, very niche market. Their tradeshows booth is quite impressive...but that doesn't mean impressive sales.
👍️0
teq0904 teq0904 6 년 전
CEO got 2M shares in the market now.
👍️0
teq0904 teq0904 6 년 전
Jan 30 cc and presentation shows the potential markets. Just sign into it and you end up with the archive. https://edge.media-server.com/m6/p/rzpqebyy
👍️0
Macaveli Macaveli 6 년 전
Decent news released today. Plus insiders are buying. This is a hidden gem.
👍️0
teq0904 teq0904 6 년 전
Sales are slow for this startup, however the products are superb so I imagine it will be a good company in the long run. I used the oral rinse and shampoo for my dog. I don't know if the rinse is the reason, but the vet told me this month that her teeth are in excellent shape for her age.
She also had a bad itch last winter and scratched day and night. It didn't stop with the use of a vet's prescription shampoo, so I tried the Kane product with excellent results. As soon as I put it on her she stops scratching for about 1 day, so I just apply it once daily wherever I see her scratching.

I know a guy who had terrible psoriasis itching on the scalp all day and night long but it all stopped when he used the human shampoo.
👍️0

최근 히스토리

Delayed Upgrade Clock